These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14579809)

  • 41. Supporting the work of lesser geniuses: an argument for removing obstructions to human embryonic stem cell research.
    Hazuka CD
    Univ Miami Law Rev; 2002 Oct; 57(1):157-220. PubMed ID: 15156896
    [No Abstract]   [Full Text] [Related]  

  • 42. International patent protection for HIV-related therapies: patent attorney's perspective.
    Pavento LC; Greene JL; McDonald JK
    Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
    [No Abstract]   [Full Text] [Related]  

  • 43. AIDS group takes aim at pharmaceutical firm's patents, prices.
    AIDS Policy Law; 2002 Jul; 17(13):4. PubMed ID: 12162289
    [No Abstract]   [Full Text] [Related]  

  • 44. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 45. Amgen cholesterol antibody feud could kill key IP rule.
    Ratner M
    Nat Biotechnol; 2017 Dec; 35(12):1118-1119. PubMed ID: 29220019
    [No Abstract]   [Full Text] [Related]  

  • 46. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
    Hoffman DC
    Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
    [No Abstract]   [Full Text] [Related]  

  • 47. Robert Stoll. Interview by Charlotte Harrison.
    Stoll R
    Nat Rev Drug Discov; 2009 Dec; 8(12):926. PubMed ID: 19949397
    [No Abstract]   [Full Text] [Related]  

  • 48. Navigating the Hatch-Waxman Act's safe harbor.
    Jones PB
    Food Drug Law J; 2002; 57(3):475-89. PubMed ID: 12710407
    [No Abstract]   [Full Text] [Related]  

  • 49. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 50. US concedes on cheaper drug production in Brazil.
    Gottlieb S
    BMJ; 2001 Jul; 323(7303):12. PubMed ID: 11440934
    [No Abstract]   [Full Text] [Related]  

  • 51. A nail in the coffin for DNA sequence patents?
    Yamanaka M
    Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072
    [No Abstract]   [Full Text] [Related]  

  • 52. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 53. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 54. Cabilly patent finale.
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):846. PubMed ID: 18688222
    [No Abstract]   [Full Text] [Related]  

  • 55. "Ganske" threatens biotechnology patents worldwide.
    Glaser V
    Nat Biotechnol; 1997 Feb; 15(2):121. PubMed ID: 9035128
    [No Abstract]   [Full Text] [Related]  

  • 56. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 57. Overview of the Hatch-Waxman Act and its impact on the drug development process.
    Mossinghoff GJ
    Food Drug Law J; 1999; 54(2):187-94. PubMed ID: 11758572
    [No Abstract]   [Full Text] [Related]  

  • 58. Amgen preserves erythropoietin monopoly for now.
    Chahine K
    Nat Biotechnol; 2001 Mar; 19(3):188. PubMed ID: 11231519
    [No Abstract]   [Full Text] [Related]  

  • 59. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 60. Old drugs, new uses: solving a Hatch-Waxman patent predicament.
    McPhie DC
    Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.